ONCAlert | 2018 Gastrointestinal Cancers Symposium
Videos  >  

Exploring Durvalumab With Radiation Therapy in Patients With Urothelial Carcinoma

Monika Joshi, MD
Published Online:11:28 PM, Thu February 8, 2018

During the 2018 Genitourinary Cancers Symposium, Monika Joshi, MD, assistant professor, Penn State Hershey Medical Center, shared resuts of a phase Ib study of durvalumab (Imfinzi) and radiation therapy (DUART) followed by adjuvant durvalumab in patients with bladder cancer.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.